Online GLP-1 Programs in Wyoming

Insurance

Does Wyoming Medicaid cover GLP-1s?

Wyoming Medicaid does not cover GLP-1s for weight loss (KFF, 2026; RX Index, 2026). Wyoming is one of the roughly ten states that did not expand Medicaid, so its program reaches a narrow population to begin with, with about 9,000 adults in the coverage gap. GLP-1s for type 2 diabetes are covered, as federal law requires.

Online Access

Getting a GLP-1 online in Wyoming

GLP-1s are not controlled substances, so Wyoming allows them to be prescribed via telehealth, but the clinician generally must hold a Wyoming license to establish care, with only narrow out-of-state exemptions. Given Wyoming's frontier geography, telehealth is an important route for residents seeking these drugs.

Compounding

Compounded semaglutide & tirzepatide in Wyoming

Routine compounding of semaglutide and tirzepatide ended after the FDA resolved the shortages in early 2025 (FDA, 2025). Wyoming adds no special carve-out beyond the federal 503A/503B framework, so compounding is limited to documented, patient-specific clinical need.

Demand

Where GLP-1 demand is highest in Wyoming

About 33% of Wyoming adults have obesity and roughly 10% have diagnosed diabetes (CDC BRFSS via America's Health Rankings, 2024). Demand centers on Cheyenne and Casper. As the least populous, frontier state that did not expand Medicaid, Wyoming offers little public coverage for weight loss, so most access runs through cash-pay and telehealth.

Questions

Wyoming GLP-1 FAQ

Compound Guides

The GLP-1s behind these programs

Sources

How we sourced this page

Coverage, prevalence, and policy figures are drawn from primary and authoritative sources, last reviewed June 2026.